Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Molecular Templates Inc
MTEMCurrent price
1.36 USD
+0.03 USD (+2.26%)
Last closed
1.31 USD
Company
www.mtem.com
ISIN
US6085501095
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
7 835 475 USD
Yield for 12 month
-79.97 %
1Y
3Y
5Y
10Y
15Y
MTEM
Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases in the United States. The company develops therapies through its proprietary biologic drug platform technology (ETB). It is also developing MT- 8421, an ETB candidate that is in Phase I clinical trial for the treatment of dismantling TME through direct cell-kill of tumor and immune cell; MT-0169, which is in Phase I clinical trial to treat relapsed/refractory multiple myeloma; and MT-6402 in that is in Phase I clinical trial for relapsed/refractory patients with PD-L1 expressing tumors. The company has a collaboration agreement with Bristol Myers Squibb to discover and develop novel products containing ETBs directed to multiple targets. Molecular Templates, Inc. was founded in 2001 and is headquartered in Austin, Texas. Address: 9301 Amberglen Boulevard, Austin, TX, United States, 78729
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
18 USDP/E ratio
–Dividend Yield
–Current Year
+57 306 000 USD
Last Year
+19 754 000 USD
Current Quarter
+572 000 USD
Last Quarter
+11 086 000 USD
Current Year
+50 395 000 USD
Last Year
+11 954 000 USD
Current Quarter
-504 000 USD
Last Quarter
+9 935 000 USD
Key Figures MTEM
1 year
3 years
5 years
10 years
EBITDA
-13 865 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-37.88 %
PEG Ratio
–
Return On Equity TTM
-929.14 %
Wall Street Target Price
18 USD
Revenue TTM
25 470 000 USD
Book Value
1.08 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-91.7 %
Dividend Yield
–
Gross Profit TTM
-45 968 000 USD
Earnings per share
-3.05 USD
Diluted Eps TTM
-3.05 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
-97.2 %
Profit Margin
-61.35 %
Dividend Analytics MTEM
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History MTEM
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:15
Payout Ratio
–
Last Split Date
14.08.2023
Dividend Date
02.08.2017
Stock Valuation MTEM
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
0.2797
Price Sales TTM
0.3076
Enterprise Value EBITDA
0.1468
Price Book MRQ
1.1019
Financials MTEM
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators MTEM
For 52 weeks
1 USD
7.19 USD
50 Day MA
1.41 USD
Shares Short Prior Month
175 493
200 Day MA
2.35 USD
Short Ratio
8.92
Shares Short
179 337
Short Percent
3.88 %
BeatStart